In cancers, loss of nuclear IL-16 leads to hyperproliferative states, which are more difficult to target, but neutralization of secreted IL-16 could improve outcomes of chemotherapy and modulate tumor escape mechanism. This evidence concerns the gene IL16 and neoplasm.